The Lancet Oncology
Công bố khoa học tiêu biểu
Sắp xếp:
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
The Lancet Oncology - Tập 9 - Trang 1039-1047 - 2008
The Pill's gestation: from birth control to cancer prevention
The Lancet Oncology - Tập 16 Số 9 - Trang 1004-1006 - 2015
Improvement of surgical results for pancreatic cancer
The Lancet Oncology - Tập 14 Số 11 - Trang e476-e485 - 2013
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
The Lancet Oncology - Tập 21 Số 1 - Trang e18-e28 - 2020
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial
The Lancet Oncology - Tập 23 - Trang 650-658 - 2022
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial
The Lancet Oncology - Tập 8 Số 4 - Trang 304-310 - 2007
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
The Lancet Oncology - Tập 13 Số 1 - Trang 25-32 - 2012
Breast cancer in Mexico: a growing challenge to health and the health system
The Lancet Oncology - Tập 13 Số 8 - Trang e335-e343 - 2012
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
The Lancet Oncology - Tập 15 Số 1 - Trang 48-58 - 2014
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
The Lancet Oncology - Tập 11 Số 8 - Trang 725-732 - 2010
Tổng số: 1,469
- 1
- 2
- 3
- 4
- 5
- 6
- 147